Use of piperazine sulfonic acid derivatives as ccr1...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/495 (2006.01) A61P 25/00 (2006.01) A61P 25/18 (2006.01) A61P 29/00 (2006.01) A61P 31/12 (2006.01)

Patent

CA 2500850

The present invention relates to methods of using CCR1 antagonists as immunomodulatory agents. In particular, the methods relate to using compounds of the formula (I) or the pharmaceutically acceptable salt thereof; wherein X, Y, a, b, c, d, R1, R2, R3 and R5 are as defined herein.

La présente invention concerne des procédés d'utilisation d'antagonistes CCR1 en tant qu'agents immunomodulateurs. Notamment, les procédés utilisent des composés de la formule (I) ou le sel correspondant acceptable pharmaceutiquement, X, Y, a, b, c, d, R?1¿, R?2¿, R?3¿ et R?5¿ étant tels que définis dans l'invention.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Use of piperazine sulfonic acid derivatives as ccr1... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of piperazine sulfonic acid derivatives as ccr1..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of piperazine sulfonic acid derivatives as ccr1... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1438924

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.